Published Date: 07 Aug 2025
Researchers from Helmholtz Munich, the Technical University of Munich (TUM), and the Medical University of Vienna have developed an advanced imaging technique called "O2E" that allows clinics to detect cancerous lesions in ...
Read Full News1.
Imetelstat for MDS-relateret anemia er godkendt af Food and Drug Administrations panel.
2.
Prior authorizations draining time, energy from many cancer patients
3.
FDA Expands Approval of Osimertinib in Lung Cancer
4.
Increased detection of adenomas may reduce colon cancer risk after colonoscopy in FIT-based screening.
5.
Specialist Referrals Are Critical for Functional High-Risk Multiple Myeloma
1.
Integrated Frameworks in Hematology in Clinical Decision-Making
2.
Amivantamab Plus Chemotherapy Outperforms Standard Care in Post-Osimertinib NSCLC
3.
Practical Breakthroughs in Oncology Across Clinical Settings
4.
Obesity as a major risk factor for cancer
5.
Next-Generation Sequencing in Oncology: Unlocking the Future of Precision Medicine
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
International Lung Cancer Congress®
1.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases - Part II
2.
A Panel Discussion on Clinical Trial End Point for Tumor With PPS > 12 months
3.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part I
4.
The Landscape of First-Line Treatment for Urothelial Carcinoma- The Conclusion
5.
INO-VATE: The Long-Term Overall Survival Analysis in Iontuzumab-Treated Patients
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation